Amylyx Pharmaceuticals: Avexitide define a reconstrução endócrina (NASDAQ:AMLX)

· seekingalpha.com

Amylyx muda o foco para a endocrinologia com o avexitide no ensaio de Fase 3 LUCIDITY para hipoglicemia pós-bariátrica; reserva de caixa até 2028. Clique aqui para ler mais.

Amylyx Pharmaceuticals ( AMLX ) is still frequently viewed through the lens of RELYVRIO (and ultimately the unsuccessful PHOENIX confirmatory trial) in ALS. How...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI